Luminescence-based complementation assay to assess target engagement and cell permeability of glycolate oxidase (HAO1) inhibitors

Author:

Mackinnon Sabrina R.,Zarganes-Tzitzikas Tryfon,Adams Cassandra J.,Brennan Paul E.,Yue Wyatt W.

Abstract

AbstractGlycolate oxidase (HAO1) catalyses the synthesis of glyoxylate, a common metabolic intermediate that causes renal failure if accumulated. HAO1 inhibition is an emerging treatment for primary hyperoxaluria, a rare disorder of glyoxylate metabolism. Here we report the first cell-based measurement of inhibitor uptake and engagement with HAO1, by adapting the cellular thermal shift assay (CETSA) based on Nano luciferase complementation and luminescence readout. By profiling the interaction between HAO1 and four well-characterised inhibitors in intact and lysed HEK293T cells, we showed that our CETSA method differentiates between low-permeability/high-engagement and high-permeability/low-engagement ligands and is able to rank HAO1 inhibitors in line with both recombinant protein methods and previously reported indirect cellular assays. Our methodology addresses the unmet need for a robust, sensitive, and scalable cellular assay to guide HAO1 inhibitor development and, in broader terms, can be rapidly adapted for other targets to simultaneously monitor compound affinity and cellular permeability.

Publisher

Cold Spring Harbor Laboratory

Reference40 articles.

1. Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I

2. Primary Hyperoxaluria

3. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

4. Maag, H. , Fernandes, M.X. , Zamboni, R. , Akbariromani, E. , Beaulieu, M.A. , Leblanc, Y. , and Thakur, P. (2020). Triazole glycolate oxidase inhibitors. World Intellectual Property Organization, WO2020010309A1. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020010309

5. Wang, B. , and Chao, Q. (2023). Glycolate oxidase inhibitors for the treatment of disease. US Patent and Trademark Office, US20230089374A1. https://patentcenter.uspto.gov/applications/17751144.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3